My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 72

    1.

    Comparison of once- versus twice-daily administration of insulin detemir, used with mealtime insulin aspart, in basal-bolus therapy for type 1 diabetes: assessment of detemir administration in a progressive treat-to-target trial (ADAPT).

    Le Floch JP, Lévy M, Mosnier-Pudar H, Nobels F, Laroche S, Gonbert S, Eschwege E, Fontaine P; Assessment of Detemir Administration in Progressive Treat-to-Target Trial (ADAPT) Study Group.

    Diabetes Care. 2009 Jan;32(1):32-7. Epub 2008 Oct 22.PMID: 18945928 [PubMed - in process]Related articlesFree article

    2.

    Comparison of insulin detemir and insulin glargine in a basal-bolus regimen, with insulin aspart as the mealtime insulin, in patients with type 1 diabetes: a 52-week, multinational, randomized, open-label, parallel-group, treat-to-target noninferiority trial.

    Heller S, Koenen C, Bode B.

    Clin Ther. 2009 Oct;31(10):2086-97.PMID: 19922879 [PubMed - in process]Related articles

    3.

    A randomised, 52-week, treat-to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes.

    Rosenstock J, Davies M, Home PD, Larsen J, Koenen C, Schernthaner G.

    Diabetologia. 2008 Mar;51(3):408-16. Epub 2008 Jan 16.PMID: 18204830 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial.

    Bartley PC, Bogoev M, Larsen J, Philotheou A.

    Diabet Med. 2008 Apr;25(4):442-9.PMID: 18387078 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Effects of QD insulin detemir or neutral protamine Hagedorn on blood glucose control in patients with type I diabetes mellitus using a basal-bolus regimen.

    Russell-Jones D, Simpson R, Hylleberg B, Draeger E, Bolinder J.

    Clin Ther. 2004 May;26(5):724-36.PMID: 15220016 [PubMed - indexed for MEDLINE]Related articles

    6.

    The 12-month efficacy and safety of insulin detemir and NPH insulin in basal-bolus therapy for the treatment of type 1 diabetes.

    Standl E, Lang H, Roberts A.

    Diabetes Technol Ther. 2004 Oct;6(5):579-88.PMID: 15628811 [PubMed - indexed for MEDLINE]Related articles

    7.

    Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes.

    Philis-Tsimikas A, Charpentier G, Clauson P, Ravn GM, Roberts VL, Thorsteinsson B.

    Clin Ther. 2006 Oct;28(10):1569-81. Erratum in: Clin Ther. 2006 Nov;28(11):1967. PMID: 17157113 [PubMed - indexed for MEDLINE]Related articles

    8.

    A 26-week, randomized, parallel, treat-to-target trial comparing insulin detemir with NPH insulin as add-on therapy to oral glucose-lowering drugs in insulin-naive people with type 2 diabetes.

    Hermansen K, Davies M, Derezinski T, Martinez Ravn G, Clauson P, Home P.

    Diabetes Care. 2006 Jun;29(6):1269-74. Erratum in: Diabetes Care. 2007 Apr;30(4):1035. PMID: 16732007 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    10.

    Effectiveness of human ultralente versus NPH insulin in providing basal insulin replacement for an insulin lispro multiple daily injection regimen. A double-blind randomized prospective trial. The Canadian Lispro Study Group.

    Zinman B, Ross S, Campos RV, Strack T.

    Diabetes Care. 1999 Apr;22(4):603-8.PMID: 10189539 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Advancing insulin therapy in type 2 diabetes previously treated with glargine plus oral agents: prandial premixed (insulin lispro protamine suspension/lispro) versus basal/bolus (glargine/lispro) therapy.

    Rosenstock J, Ahmann AJ, Colon G, Scism-Bacon J, Jiang H, Martin S.

    Diabetes Care. 2008 Jan;31(1):20-5. Epub 2007 Oct 12.PMID: 17934150 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial.

    Home P, Bartley P, Russell-Jones D, Hanaire-Broutin H, Heeg JE, Abrams P, Landin-Olsson M, Hylleberg B, Lang H, Draeger E; Study to Evaluate the Administration of Detemir Insulin Efficacy, Safety and Suitability (STEADINESS) Study Group.

    Diabetes Care. 2004 May;27(5):1081-7.PMID: 15111525 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.

    Rossetti P, Pampanelli S, Fanelli C, Porcellati F, Costa E, Torlone E, Scionti L, Bolli GB.

    Diabetes Care. 2003 May;26(5):1490-6.PMID: 12716810 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Twice-daily compared with once-daily insulin glargine in people with Type 1 diabetes using meal-time insulin aspart.

    Ashwell SG, Gebbie J, Home PD.

    Diabet Med. 2006 Aug;23(8):879-86.PMID: 16911626 [PubMed - indexed for MEDLINE]Related articles

    15.

    Insulin detemir compared with NPH insulin in children and adolescents with Type 1 diabetes.

    Robertson KJ, Schoenle E, Gucev Z, Mordhorst L, Gall MA, Ludvigsson J.

    Diabet Med. 2007 Jan;24(1):27-34.PMID: 17227321 [PubMed - indexed for MEDLINE]Related articles

    16.

    How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus?

    Marks JB.

    Nat Clin Pract Endocrinol Metab. 2008 Sep;4(9):490-1. Epub 2008 Jul 1. Erratum in: Nat Clin Pract Endocrinol Metab. 2008 Dec;4(12):702. dosage error in text. PMID: 18594486 [PubMed]Related articles

    17.

    Comparison of the soluble basal insulin analog insulin detemir with NPH insulin: a randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy.

    Hermansen K, Madsbad S, Perrild H, Kristensen A, Axelsen M.

    Diabetes Care. 2001 Feb;24(2):296-301.PMID: 11213882 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Comparison of pharmacokinetics and dynamics of the long-acting insulin analogs glargine and detemir at steady state in type 1 diabetes: a double-blind, randomized, crossover study.

    Porcellati F, Rossetti P, Busciantella NR, Marzotti S, Lucidi P, Luzio S, Owens DR, Bolli GB, Fanelli CG.

    Diabetes Care. 2007 Oct;30(10):2447-52. Epub 2007 Jul 10. Erratum in: Diabetes Care. 2008 Jan;31(1):188. PMID: 17623819 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Insulin detemir: a long-acting insulin product.

    Jones MC, Patel M.

    Am J Health Syst Pharm. 2006 Dec 15;63(24):2466-72. Review. Erratum in: Am J Health Syst Pharm. 2007 Feb 15;64(4):346. PMID: 17158694 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effect of insulin detemir dose frequency on clinical outcomes in patients with diabetes in PREDICTIVE.

    Fontaine P, Gin H, Pinget M, Thivolet C, Hanaire H, Robert JJ, Marre M, Venkatanarasimhachar S.

    Adv Ther. 2009 May;26(5):535-51. Epub 2009 Jun 2.PMID: 19513632 [PubMed - in process]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity